Doctors across the country are rethinking one of the most commonly prescribed classes of blood pressure medication — ACE inhibitors — after a landmark 2025 study in The Lancet found that thiazide diuretics are more effective and cause fewer side effects as a first-line treatment. The study, which analyzed 4.9 million patients across nine databases, showed that thiazide users experienced roughly 15 percent fewer major cardiovascular events, including heart attacks, strokes, and heart failure hospitalizations, compared to those started on ACE inhibitors. That finding alone has prompted many physicians to switch patients to alternatives, particularly when side effects like persistent dry cough make ACE inhibitors hard to tolerate. But ACE inhibitors are not the only blood pressure drugs under scrutiny. A wave of FDA recalls in 2025 and 2026 has pulled hundreds of thousands of bottles of common BP medications off pharmacy shelves due to cancer-causing nitrosamine contamination and cross-contamination with unrelated drugs.
Prazosin, bisoprolol/hydrochlorothiazide, and amlodipine/olmesartan have all been affected. For the millions of Americans managing hypertension — and especially for older adults concerned about dementia risk — these developments demand attention. This article covers why doctors are making these switches, what the recalls mean for you, and how to talk to your physician about whether your current medication is still the right choice. The stakes extend well beyond blood pressure numbers. The American Heart Association and American College of Cardiology released updated hypertension guidelines in late 2025 emphasizing that uncontrolled high blood pressure raises the risk of dementia and cognitive decline. For readers of this site, that connection makes proper medication selection not just a cardiovascular issue but a brain health issue.
Table of Contents
- Why Are Doctors Switching Patients Off ACE Inhibitors — And What Are They Prescribing Instead?
- The Recall Crisis — Which Blood Pressure Medications Have Been Pulled From Shelves
- The Dementia Connection — Why Blood Pressure Management Matters for Your Brain
- What to Do If Your Medication Was Recalled — A Step-by-Step Approach
- The Nitrosamine Problem Is Not Going Away
- Amlodipine and the Swelling Problem
- Where Blood Pressure Treatment Is Headed
- Conclusion
- Frequently Asked Questions
Why Are Doctors Switching Patients Off ACE Inhibitors — And What Are They Prescribing Instead?
The short answer is that the evidence caught up with prescribing habits, and the evidence says thiazide diuretics should be the go-to first choice for most patients starting blood pressure treatment. The Lancet study estimated that more than 3,100 major cardiovascular events could have been avoided if approximately 2.4 million patients who were newly started on ACE inhibitors had been prescribed thiazides instead. That is not a marginal difference. It represents real heart attacks, real strokes, and real hospitalizations that might not have happened under a different prescription. Despite these numbers, prescribing patterns remain stubbornly slow to change. As of the study’s publication, 48 percent of patients beginning blood pressure treatment were still being started on ACE inhibitors, while only 17 percent received thiazides. Doctors are creatures of habit, and ACE inhibitors like lisinopril and enalapril have been default choices for decades.
But this data is difficult to ignore, especially when ACE inhibitor users experienced higher rates of 19 different potential side effects compared to thiazide users. Thiazides had higher rates of only two side effects. For many physicians, the risk-benefit calculation has simply shifted. The most common reason individual patients get switched off ACE inhibitors is the persistent dry cough that affects roughly 10 to 15 percent of users. It is not dangerous, but it is maddening — a tickling, hacking cough that does not go away as long as you take the drug. The typical replacement is an ARB, or angiotensin receptor blocker, which works through a similar mechanism without triggering the cough. But for patients who have never been on any BP medication, the new evidence suggests starting with a thiazide may be the smarter move from day one.
The Recall Crisis — Which Blood Pressure Medications Have Been Pulled From Shelves
The ACE inhibitor question is a matter of optimization. The recall crisis is a matter of contamination, and it has hit multiple classes of blood pressure drugs. The largest recent recall involves prazosin, manufactured by Teva Pharmaceuticals. More than 580,000 bottles across 1 mg, 2 mg, and 5 mg strengths were recalled due to elevated levels of nitrosamine impurities — compounds classified as probable carcinogens. The affected bottles have expiration dates ranging from October 2025 to February 2028, meaning many are still sitting in medicine cabinets right now. Prazosin is not an isolated case. Glenmark Pharmaceuticals saw its Ziac product hit with an FDA Class III recall after 11,100 bottles were found to be cross-contaminated with ezetimibe, a cholesterol drug that was never supposed to be in those pills.
Unichem recalled its bisoprolol/hydrochlorothiazide combination over nitrosamine impurities exceeding FDA limits. And Ascend Laboratories pulled 8,568 bottles of amlodipine/olmesartan in August 2025 because the tablets failed dissolution specifications, meaning they were not breaking down properly in the body and may not have been delivering the intended dose. However, and this is critical, the FDA issued explicit guidance on February 7, 2026 telling patients not to stop taking affected medications without consulting their doctor first. The reasoning is straightforward: the risk of uncontrolled blood pressure — which can cause stroke, heart attack, or kidney failure in the short term — generally outweighs the risk posed by low-level contamination. If you discover your medication is on a recall list, call your doctor or pharmacist. Do not flush your pills and go without. The goal is a supervised switch, not an abrupt stop.
The Dementia Connection — Why Blood Pressure Management Matters for Your Brain
The updated 2025 guidelines from the American Heart Association and American College of Cardiology did something that previous guidelines had underemphasized: they drew a direct line between uncontrolled hypertension and the risk of dementia and cognitive decline. This is not new science — researchers have known for years that chronic high blood pressure damages the small blood vessels in the brain — but elevating it in official guidelines gives doctors a stronger basis for aggressive treatment and for getting medication choices right. For someone in their 50s or 60s managing high blood pressure, the choice of which drug to take is not just about preventing a heart attack next year. It is about protecting cognitive function over the next two or three decades. Poorly controlled hypertension in midlife is one of the strongest modifiable risk factors for Alzheimer’s disease and vascular dementia later on.
This makes the Lancet study’s findings particularly relevant for this audience: if thiazides prevent more cardiovascular events and come with fewer side effects, they may also do a better job protecting the brain over time simply by keeping blood pressure under tighter control with better adherence. There is a practical dimension here too. Side effects drive patients to stop taking their medication. If ACE inhibitors cause a cough that makes someone quit their pills, or if amlodipine causes ankle swelling severe enough that a patient decides it is not worth it, the result is the same — uncontrolled blood pressure doing silent damage to the brain. The best blood pressure drug is the one a patient will actually take consistently. For many people, that turns out to be a thiazide diuretic.
What to Do If Your Medication Was Recalled — A Step-by-Step Approach
If you are taking prazosin, Ziac, bisoprolol/hydrochlorothiazide, or amlodipine/olmesartan, the first step is checking whether your specific lot number is affected. This information is available on the FDA’s recall database and was widely reported by outlets including AARP and UConn Today. Your pharmacist can also look this up for you with your prescription records. The second step is calling your prescribing doctor, not stopping your medication on your own. Your doctor may switch you to the same drug from a different manufacturer that was not affected by the recall, or they may use this as an opportunity to reevaluate your entire regimen.
For someone on prazosin who has been dealing with side effects, a recall might be the push needed to try a different class entirely. For someone stable on amlodipine/olmesartan from Ascend Laboratories, the fix might be as simple as getting the same combination from another generic manufacturer. The tradeoff worth understanding is this: switching drug classes means a period of adjustment. Going from an ACE inhibitor to a thiazide, for example, may involve monitoring electrolytes more closely for the first few months, since thiazides can lower potassium levels. Going from amlodipine to an ARB means losing amlodipine’s particular effectiveness for certain types of angina. These are not reasons to avoid switching — they are reasons to do it with your doctor’s guidance rather than on your own.
The Nitrosamine Problem Is Not Going Away
The prazosin recall is part of a much larger pattern. Nitrosamine contamination has been a recurring issue in generic blood pressure medications since the massive valsartan recalls that began in 2018, followed by losartan and irbesartan recalls in subsequent years. The root cause often traces back to changes in manufacturing processes at overseas facilities, where certain chemical reactions or solvent choices inadvertently produce nitrosamines as byproducts. The FDA has tightened its acceptable intake limits for nitrosamines and now requires manufacturers to test for these impurities, but the recalls keep coming. This does not mean generic drugs are unsafe as a category — the vast majority of generic blood pressure medications are perfectly fine.
But it does mean patients and doctors need to stay informed. If you are on a generic BP medication and your pharmacy switches manufacturers on you, which happens regularly based on supply contracts, it is worth asking your pharmacist whether the new manufacturer has had any recent recall issues. One important limitation to keep in mind: the cancer risk from nitrosamine contamination at the levels found in these recalls is generally considered low on an individual basis. The FDA’s own guidance frames it as a precautionary measure. You are not in immediate danger if you took a contaminated batch. The concern is cumulative exposure over years, which is why the recalls happen even when the contamination levels are relatively modest.
Amlodipine and the Swelling Problem
Amlodipine deserves special mention because it is one of the most widely prescribed blood pressure drugs in the world and has a side effect profile that frequently prompts switching. Peripheral edema — swelling in the ankles and lower legs — is the most common complaint. It occurs because amlodipine dilates arteries but not veins, creating a pressure imbalance that pushes fluid into surrounding tissue.
The swelling is not dangerous in itself, but it is uncomfortable, cosmetically distressing, and often mistaken for a sign of heart failure, which leads to unnecessary panic and testing. The standard workaround is to add a low-dose thiazide diuretic, which can counteract the fluid retention, or to switch to an ACE inhibitor or ARB. For patients already tolerating amlodipine well without swelling, there is no reason to switch based on the Lancet study alone — that study focused on first-line treatment choices, not on patients already stable on a regimen. But for anyone starting treatment fresh, the evidence now favors trying a thiazide before reaching for amlodipine or an ACE inhibitor.
Where Blood Pressure Treatment Is Headed
The convergence of new clinical evidence, updated guidelines, and ongoing safety recalls is reshaping how hypertension is managed in the United States. Expect to see thiazide prescriptions rise over the next several years as the Lancet findings filter into clinical practice and updated treatment algorithms. The 48-to-17 percent gap between ACE inhibitor and thiazide prescribing is almost certainly going to narrow.
For patients concerned about brain health and dementia prevention, this shift is encouraging. More effective blood pressure control with fewer side effects means better long-term adherence, and better adherence means less silent vascular damage accumulating in the brain over decades. The best thing any patient can do right now is have an honest conversation with their doctor about whether their current medication is still the best option — not just for their heart, but for their mind.
Conclusion
The landscape of blood pressure treatment is changing on two fronts simultaneously. On the evidence side, a major study of nearly five million patients has shown that thiazide diuretics outperform ACE inhibitors as first-line therapy, with fewer side effects and roughly 15 percent fewer major cardiovascular events. On the safety side, recalls affecting prazosin, Ziac, bisoprolol/hydrochlorothiazide, and amlodipine/olmesartan have put hundreds of thousands of medication bottles under scrutiny for nitrosamine contamination and other manufacturing failures. The takeaway is not to panic, and it is certainly not to stop taking your blood pressure medication without medical guidance.
The takeaway is to be proactive. Check whether your specific medication lot has been recalled. Ask your doctor whether a thiazide might be a better fit than your current ACE inhibitor. And remember that controlling your blood pressure is one of the most powerful things you can do to protect your brain as you age. The science on this point is clear, and the updated 2025 AHA/ACC guidelines have made it official: uncontrolled hypertension is a direct risk factor for dementia and cognitive decline.
Frequently Asked Questions
Should I stop taking my blood pressure medication if it has been recalled?
No. The FDA’s February 2026 guidance is explicit — do not stop taking your medication without consulting your doctor. The risk of uncontrolled blood pressure, including stroke and heart attack, generally outweighs the risk from contamination. Call your doctor or pharmacist to arrange a safe switch.
Are thiazide diuretics better than ACE inhibitors for everyone?
Not necessarily. The Lancet study focused on first-line treatment in patients starting blood pressure therapy. If you are already stable on an ACE inhibitor with good blood pressure control and no bothersome side effects, your doctor may see no reason to switch. The data is strongest for people beginning treatment for the first time.
What is nitrosamine and how dangerous is it?
Nitrosamines are chemical compounds classified as probable carcinogens. At the low levels found in recalled medications, the individual cancer risk is considered small by the FDA. The concern is cumulative exposure over months or years of daily use, which is why recalls are issued even when contamination levels are modest.
Does high blood pressure really cause dementia?
Chronic uncontrolled hypertension damages small blood vessels throughout the brain and is one of the strongest modifiable risk factors for both vascular dementia and Alzheimer’s disease. The 2025 AHA/ACC guidelines formally emphasized this connection, particularly for hypertension in midlife.
Why do ACE inhibitors cause a cough?
ACE inhibitors block the breakdown of a substance called bradykinin, which accumulates in the lungs and can trigger a persistent, dry cough. This affects approximately 10 to 15 percent of users and is the most common reason patients are switched from ACE inhibitors to ARBs, which do not have this effect.
How do I know if my specific medication lot was recalled?
Check the FDA’s official recall page or contact your pharmacy directly. Your pharmacist can cross-reference your prescription records with recalled lot numbers and expiration dates to determine whether your specific bottles are affected.
